Quality of Life after PCI with Drug-Eluting Stents or Coronary-Artery Bypass Surgery

被引:193
作者
Cohen, David J. [1 ]
Van Hout, Ben [2 ]
Serruys, Patrick W. [3 ]
Mohr, Friedrich W. [5 ]
Macaya, Carlos [6 ]
den Heijer, Peter [4 ]
Vrakking, M. M. [4 ]
Wang, Kaijun [1 ]
Mahoney, Elizabeth M. [1 ]
Audi, Salma [7 ]
Leadley, Katrin [7 ]
Dawkins, Keith D. [7 ]
Kappetein, A. Pieter [3 ]
机构
[1] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA
[2] Univ Sheffield, Sheffield, S Yorkshire, England
[3] Erasmus Univ, Med Ctr Rotterdam, Rotterdam, Netherlands
[4] Amphia Ziekenhuis, Breda, Netherlands
[5] Univ Leipzig, Herzzentrum, Leipzig, Germany
[6] Hosp Clin Univ San Carlos, Madrid, Spain
[7] Boston Sci, Natick, MA USA
关键词
HEALTH-STATUS; ANGIOPLASTY; DISEASE; RANDOMIZATION; INTERVENTION; SF-36; COSTS;
D O I
10.1056/NEJMoa1001508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Previous studies have shown that among patients undergoing multivessel revascularization, coronary-artery bypass grafting (CABG), as compared with percutaneous coronary intervention (PCI) either by means of balloon angioplasty or with the use of bare-metal stents, results in greater relief from angina and improved quality of life. The effect of PCI with the use of drug-eluting stents on these outcomes is unknown. METHODS In a large, randomized trial, we assigned 1800 patients with three-vessel or left main coronary artery disease to undergo either CABG (897 patients) or PCI with paclitaxeleluting stents (903 patients). Health-related quality of life was assessed at baseline and at 1, 6, and 12 months with the use of the Seattle Angina Questionnaire (SAQ) and the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36). The primary end point was the score on the angina-frequency subscale of the SAQ (on which scores range from 0 to 100, with higher scores indicating better health status). RESULTS The scores on each of the SAQ and SF-36 subscales were significantly higher at 6 and 12 months than at baseline in both groups. The score on the angina-frequency subscale of the SAQ increased to a greater extent with CABG than with PCI at both 6 and 12 months (P = 0.04 and P = 0.03, respectively), but the between-group differences were small (mean treatment effect of 1.7 points at both time points). The proportion of patients who were free from angina was similar in the two groups at 1 month and 6 months and was higher in the CABG group than in the PCI group at 12 months (76.3% vs. 71.6%, P = 0.05). Scores on all the other SAQ and SF-36 subscales were either higher in the PCI group (mainly at 1 month) or were similar in the two groups throughout the follow-up period. CONCLUSIONS Among patients with three-vessel or left main coronary artery disease, there was greater relief from angina after CABG than after PCI at 6 and 12 months, although the extent of the benefit was small.
引用
收藏
页码:1016 / 1026
页数:11
相关论文
共 26 条
[1]  
[Anonymous], 1996, COST EFFECTIVENESS H, DOI DOI 10.1093/OSO/9780195108248.001.0001
[2]  
[Anonymous], 1988, Statistical power for the social sciences, DOI DOI 10.1177/002224378101800104
[3]   Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting [J].
Henderson, RA ;
Pocock, SJ ;
Sharp, SJ ;
Nanchahal, K ;
Sculpher, MJ ;
Buxton, MJ ;
Hampton, JR .
LANCET, 1998, 352 (9138) :1419-1425
[4]   Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease [J].
Hlatky, MA ;
Boothroyd, DB ;
Melsop, KA ;
Brooks, MM ;
Mark, DB ;
Pitt, B ;
Reeder, GS ;
Rogers, WJ ;
Ryan, TJ ;
Whitlow, PL ;
Wiens, RD .
CIRCULATION, 2004, 110 (14) :1960-1966
[5]   Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery [J].
Hlatky, MA ;
Rogers, WJ ;
Johnstone, I ;
Boothroyd, D ;
Brooks, MM ;
Pitt, B ;
Reeder, G ;
Ryan, T ;
Smith, H ;
Whitlow, P ;
Wiens, R ;
Mark, DB .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (02) :92-99
[6]   A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: One- to eight-year outcomes [J].
Hoffman, SN ;
TenBrook, JA ;
Wolf, MP ;
Pauker, SG ;
Salem, DN ;
Wong, JB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (08) :1293-1304
[7]   UNBALANCED REPEATED-MEASURES MODELS WITH STRUCTURED COVARIANCE MATRICES [J].
JENNRICH, RI ;
SCHLUCHTER, MD .
BIOMETRICS, 1986, 42 (04) :805-820
[8]   Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial [J].
Kedhi, Elvin ;
Joesoef, Kaiyum Sheik ;
McFadden, Eugene ;
Wassing, Jochem ;
van Mieghem, Carlos ;
Goedhart, Dick ;
Smits, Pieter Cornelis .
LANCET, 2010, 375 (9710) :201-209
[9]   The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phase [J].
Ong, Andrew T. L. ;
Serruys, Patrick W. ;
Mohr, Frederick W. ;
Morice, Marie-Claude ;
Kappetein, A. Pieter ;
Holmes, David R., Jr. ;
Mack, Michael J. ;
van den Brand, Marcel ;
Morel, Marie-Angele ;
van Es, Gerrit-Anne ;
Kleijne, Jeroen ;
Koglin, Joerg ;
Russell, Mary E. .
AMERICAN HEART JOURNAL, 2006, 151 (06) :1194-1204
[10]   Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease [J].
Serruys, Patrick W. ;
Morice, Marie-Claude ;
Kappetein, A. Pieter ;
Colombo, Antonio ;
Holmes, David R. ;
Mack, Michael J. ;
Stahle, Elisabeth ;
Feldman, Ted E. ;
van den Brand, Marcel ;
Bass, Eric J. ;
Van Dyck, Nic ;
Leadley, Katrin ;
Dawkins, Keith D. ;
Mohr, Friedrich W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (10) :961-972